Sandoz Hones Biosimilars Strategy
Novartis generics unit pursues two different approaches for the human growth hormone Omnitrope and the epoetin alfa follow-on Binocrit.
Novartis generics unit pursues two different approaches for the human growth hormone Omnitrope and the epoetin alfa follow-on Binocrit.